Xeris Biopharma Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report4 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−9.25%
vs ±14.3% implied · ×0.65
shaded = implied · ▲▼ = realized
Xeris Biopharma has 11 disclosed suppliers and 0 disclosed customers in SEC filings.
SentenceWe have entered into a non-exclusive supply agreement with Bachem.
XERS 10-Kaccession 0001867096-26-000016
SentenceFor Gvoke, we currently rely on a number of single-source suppliers, such as Bachem API, Pyramid for drug product, and SHL for auto-injector and final product assembly, and we have entered into several supply agreements including with Bachem, Pyramid and SHL.
XERS 10-Kaccession 0001867096-26-000016
SentenceSimilarly, for Recorlev, we rely on a number of single-source suppliers, such as Regis for API and Lonza for finished drug product.
XERS 10-Kaccession 0001867096-26-000016
SentenceWe have entered into a supply agreement with Lonza.
XERS 10-Kaccession 0001867096-26-000016
SentenceFor Gvoke, we currently rely on a number of single-source suppliers, such as Bachem API, Pyramid for drug product, and SHL for auto-injector and final product assembly, and we have entered into several supply agreements including with Bachem, Pyramid and SHL.
XERS 10-Kaccession 0001867096-26-000016
SentenceWe have entered into a non-exclusive supply agreement with Pyramid.
XERS 10-Kaccession 0001867096-26-000016
SentenceSimilarly, for Recorlev, we rely on a number of single-source suppliers, such as Regis for API and Lonza for finished drug product.
XERS 10-Kaccession 0001867096-26-000016
SentenceWe have entered into a supply agreement with Regis.
XERS 10-Kaccession 0001867096-26-000016
SentenceFor Gvoke, we currently rely on a number of single-source suppliers, such as Bachem API, Pyramid for drug product, and SHL for auto-injector and final product assembly, and we have entered into several supply agreements including with Bachem, Pyramid and SHL.
XERS 10-Kaccession 0001867096-26-000016
SentenceWe have entered into a supply agreement with SHL.
XERS 10-Kaccession 0001867096-26-000016
SentenceTaro produces all of our requirements for Keveyis pursuant to a supply agreement.
XERS 10-Kaccession 0001867096-26-000016
Largest filed tie
—
—
—
Expected move
Inputsspot 10.71exp Nov 20ATM strike 11ATM straddle 1.78IV 85%
Xeris Biopharma Holdings, Inc.
10.73